T. Zohoncon, W. F. Djigma, A. Ouattara, I. M. Traore, R. A. Ouédraogo, Esther M.A Traor e, P. Bado, T. C. Ouédraogo, B. Diarra, M. Ilboudo, C. D. Capo-chichi, D. Obiri-Yeboah, S. Karou, M. Nayama, A. Horo, K. P. Kouakou, M. Gomina, S. Ouattara, A. Sanni, A. Simon, C. Ouedraogo, J. Simporé
{"title":"Mapping of fourteen high-risk human papillomavirus genotypes by molecular detection in sexually active women in the West African sub-region","authors":"T. Zohoncon, W. F. Djigma, A. Ouattara, I. M. Traore, R. A. Ouédraogo, Esther M.A Traor e, P. Bado, T. C. Ouédraogo, B. Diarra, M. Ilboudo, C. D. Capo-chichi, D. Obiri-Yeboah, S. Karou, M. Nayama, A. Horo, K. P. Kouakou, M. Gomina, S. Ouattara, A. Sanni, A. Simon, C. Ouedraogo, J. Simporé","doi":"10.5897/IJGMB2019.0193","DOIUrl":null,"url":null,"abstract":"The aim of this study was to determine the distribution of high-risk human papillomavirus genotypes (HR-HPV) in women from the general population of five West African countries. This was a cross-sectional descriptive study, involving 2133 women from nine cities of five West African countries: Benin, Burkina Faso, Cote d'Ivoire, Niger and Togo. Women were screened for precancerous cervical lesions and HR-HPV infection. The detection of HR-HPV was done by a multiplex real-time PCR on extracted viral DNA. The average age of the women in this study was 35.06 ± 10.00 years with a range of 15 to 65 years. The overall prevalence of high-risk HPV infection among general population sample of women in five West African countries was 33.61% (717/2133). The prevalence of dysplasia was 8.81%. In decreasing order of frequency, the genotypes found were: HPV 52 followed by HPV 31, 59, 51, 66, 45, 68, 56, 56, 58, 35, 39, 18, 33 and 16. The prevalence of HPV16/18 (bivalent vaccine types) was 7.02%. This study reveals a high prevalence of HPV 52 in West Africa. The extent and diversity of HR-HPV genotypes in these West African countries deserve special attention for prevention. \n \n \n \n Key words: High-risk HPV, real time PCR, genotypes, women, epidemiology, West Africa.","PeriodicalId":88902,"journal":{"name":"International journal of genetics and molecular biology","volume":"78 1","pages":"11-21"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of genetics and molecular biology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5897/IJGMB2019.0193","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5
Abstract
The aim of this study was to determine the distribution of high-risk human papillomavirus genotypes (HR-HPV) in women from the general population of five West African countries. This was a cross-sectional descriptive study, involving 2133 women from nine cities of five West African countries: Benin, Burkina Faso, Cote d'Ivoire, Niger and Togo. Women were screened for precancerous cervical lesions and HR-HPV infection. The detection of HR-HPV was done by a multiplex real-time PCR on extracted viral DNA. The average age of the women in this study was 35.06 ± 10.00 years with a range of 15 to 65 years. The overall prevalence of high-risk HPV infection among general population sample of women in five West African countries was 33.61% (717/2133). The prevalence of dysplasia was 8.81%. In decreasing order of frequency, the genotypes found were: HPV 52 followed by HPV 31, 59, 51, 66, 45, 68, 56, 56, 58, 35, 39, 18, 33 and 16. The prevalence of HPV16/18 (bivalent vaccine types) was 7.02%. This study reveals a high prevalence of HPV 52 in West Africa. The extent and diversity of HR-HPV genotypes in these West African countries deserve special attention for prevention.
Key words: High-risk HPV, real time PCR, genotypes, women, epidemiology, West Africa.